Potent and Specific Antibacterial Activity against Escherichia coli O157:H7 and Methicillin Resistant Staphylococcus aureus (MRSA) of G17 and G19 Peptides Encapsulated into Poly-Lactic-Co-Glycolic Acid (PLGA) Nanoparticles
- Supplementary File 1:
PDF-Document (PDF, 389 KiB)
Gómez-Sequeda, N.; Ruiz, J.; Ortiz, C.; Urquiza, M.; Torres, R. Potent and Specific Antibacterial Activity against Escherichia coli O157:H7 and Methicillin Resistant Staphylococcus aureus (MRSA) of G17 and G19 Peptides Encapsulated into Poly-Lactic-Co-Glycolic Acid (PLGA) Nanoparticles. Antibiotics 2020, 9, 384. https://doi.org/10.3390/antibiotics9070384
Gómez-Sequeda N, Ruiz J, Ortiz C, Urquiza M, Torres R. Potent and Specific Antibacterial Activity against Escherichia coli O157:H7 and Methicillin Resistant Staphylococcus aureus (MRSA) of G17 and G19 Peptides Encapsulated into Poly-Lactic-Co-Glycolic Acid (PLGA) Nanoparticles. Antibiotics. 2020; 9(7):384. https://doi.org/10.3390/antibiotics9070384
Chicago/Turabian StyleGómez-Sequeda, Nicolás; Ruiz, Jennifer; Ortiz, Claudia; Urquiza, Mauricio; Torres, Rodrigo. 2020. "Potent and Specific Antibacterial Activity against Escherichia coli O157:H7 and Methicillin Resistant Staphylococcus aureus (MRSA) of G17 and G19 Peptides Encapsulated into Poly-Lactic-Co-Glycolic Acid (PLGA) Nanoparticles" Antibiotics 9, no. 7: 384. https://doi.org/10.3390/antibiotics9070384